1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > CNS Drug News 15 DECEMBER 2014

CNS Drug News 15 DECEMBER 2014

  • December 2014
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - Unmet Medical Needs A Focus Of CNS Segment In 2014
Industry Brief - Phase III Trial Of Acorda's CVT-301 In PD Initiated
Industry Brief - Teikoku Reports Positive Study Results Of Seven-Day Patch For PD
Industry Brief - GeNeuro/Servier Enter Partnership For GNbAC1 In MS
Industry Trend Analysis - New Copaxone Dose Will Soften Impact Of Generics On Teva's Revenues
Industry Brief - First MS Patients In US Receive Genzyme's Lemtrada Following FDA Approval
Industry Trend Analysis - Gilenya's Failure Will Not Deter Interest In Progressive MS
Industry Brief - Phase III Trial Initiated For Dalfampridine In Post-Stroke Walking Deficits
Industry Brief - Eisai Demonstrates Efficacy Of Investigational DORA In Sleep Initiation And Maintenance
Industry Brief - First Patients Enrolled In Xyrem Paediatric Narcolepsy Study
Industry Brief - Edgemont Extends Marketing Exclusivity In US For Forfivo XL
Industry Brief - Naurex' GLYX-13 Shows Robust And Sustained Antidepressant Effects In Phase IIb Study
Industry Brief - FDA Approves Labelling Update For Abilify Maintena
Industry Brief - Actavis Launches Guanfacine In US
Industry Brief - Consilient Health Launches Aripiprazole In UK
Industry Brief - FDA Accepts For Review sNDA For Deltoid Administration Of Abilify Maintena
Industry Trend Analysis - 2015 Will Bring Brexpiprazole's Approval And Patent Cliff For Otsuka
Industry Brief - AcelRx Receives CE Mark Approval For Zalviso
Industry Brief - Wraser Receives FDA Approval Of Trezix For Moderate-To-Moderately Severe Pain
Industry Brief - FDA Approves Two Higher Dosage Strengths Of Zubsolv
Industry Brief - Sunovion Submits sNDA For Aptiom As MT Treatment Of POS
Industry Trend Analysis - Brivaracetam Will Help UCB Maintain A Strong Position In Epilepsy
Industry Brief - Par Adds Name To Trokendi XR Patent Challengers
Industry Brief - RedHill Submits Bekinda MAA For Oncology Support
Industry Brief - Naurex Raises Funds To Advance NMDA Receptor Modulators In Depression/Other CNS Disorders
Industry Brief - Annexon Raises Funds For Novel Approach To Neurodegenerative/Autoimmune Diseases
Industry Brief - Evgen Seeking To Raise GBP20mn In IPO On AIM
Industry Brief - CNS Conferences - March 2015

Table Of Contents

CNS Drug News 15 DECEMBER 2014

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025

  • $ 10995
  • Industry report
  • November 2016
  • by GlobalData

PharmaPoint: Schizophrenia - Global Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorde ...

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025

  • $ 6995
  • Industry report
  • November 2016
  • by GlobalData

Schizophrenia - 5EU Drug Forecast and Market Analysis to 2025 Summary Schizophrenia is a heterogeneous behavioral and cognitive syndrome involving chronic or recurrent psychosis. The disorder is characterized ...

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Neurological Disorder Drugs Market - Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Europe Neurological Disorder Drugs Market: Overview This report on the neurological disorder drugs market studies the current as well as future prospects of the market in Europe. Health concern related ...


ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.